| Filed On | Filing |
|---|---|
| 19 Oct 2026 |
Form 4: Mendelsohn Aaron, Director
Gave 20,000 shares as a gift |
| 25 Sep 2026 | 424B5 |
| 16 Sep 2026 |
8-K: Regulation FD Disclosure
As previously disclosed, Vivani Medical, Inc. (“Vivani”) entered into a definitive agreement and plan of merger among its wholly owned subsidiary Cortigent, Inc. (“Cortigent”), ClearOne, Inc. (“ClearOne”), and CLRO Merger Sub, Inc. (“Mer... |
| 17 Aug 2026 | 8-K: Regulation FD Disclosure |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 13 Aug 2026 | 10-Q |
| 06 Aug 2026 | 8-K: Regulation FD Disclosure |
| 30 Jul 2026 |
Form 4: Dwyer Donald, Chief Business Officer
Granted 70,000 Common Stock Option · Granted 35,000 RSUs |
| 30 Jul 2026 |
Form 4: Porter Lisa Ellen, Chief Medical Officer
Granted 80,000 Common Stock Option · Granted 40,000 RSUs |
| 30 Jul 2026 |
Form 4: Baldor Anthony, Chief Financial Officer
Granted 75,000 Common Stock Option · Granted 37,500 RSUs |
| 30 Jul 2026 |
Form 4: Le Truc, Chief Operations Officer
Granted 160,000 Common Stock Option · Granted 80,000 RSUs |
| 30 Jul 2026 |
Form 4: Mendelsohn Adam, Director
Granted 200,000 Common Stock Option · Granted 100,000 RSUs |
| 28 Jul 2026 |
Form 4: Bradbury Daniel, Director
Granted 7,965 Non-Qualified Stock Option (right to buy) ($10.4K) |
| 16 Jul 2026 |
Form 4: Williams Gregg, Director
Bought 793,650 shares ($1M) |
| 16 Jul 2026 | 8-K: Regulation FD Disclosure |
| 07 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 30 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more |
| 26 Jun 2026 |
Form 4: Moretti August J, Director
Granted 36,000 Non-Qualified Stock Option (right to buy) ($43.9K) |
| 26 Jun 2026 |
Form 3: Moretti August J, Director
No securities owned |
| 25 Jun 2026 |
Form 4: Williams Gregg, Director
Granted 36,516 Non-Qualified Stock Option (right to buy) ($44.5K) |
Loading...